EX-99.1 2 ea133949ex99-1_soligenix.htm INVESTOR PRESENTATION - "U.S. COMMERCIALIZATION OF SGX301 IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA."

Exhibit 99.1